Blech accused

A federal prosecutor has charged David Blech, a leading biotech financier in the early 1990s, with a single criminal count of securities fraud.

The "criminal information," which is the equivalent of an indictment but does

Read the full 347 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE